Van ECK Associates Corp Reduces Stock Position in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Van ECK Associates Corp reduced its position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 6.6% in the second quarter, reports. The firm owned 164,129 shares of the pharmaceutical company’s stock after selling 11,535 shares during the period. Van ECK Associates Corp’s holdings in Vertex Pharmaceuticals were worth $57,759,000 at the […]

Leave a Reply

Your email address will not be published.

Previous post Woodbury starts its first community garden — and fulfills one woman’s dream
Next post Van ECK Associates Corp Acquires 57,123 Shares of MP Materials Corp. (NYSE:MP)